Chemotherapy of Metastatic Carcinoma of the Breast
- 1 January 1977
- journal article
- research article
- Published by Taylor & Francis in Acta Radiologica: Therapy, Physics, Biology
- Vol. 16 (2), 97-109
- https://doi.org/10.3109/02841867709134300
Abstract
Combination chemotherapy (vincristine, adriamycin, cyclophosphamide, methotrexate with leucoverin rescue) in 32 patients with metastatic carcinoma of the breast resulted in an overall response rate of 81 per cent (9/32 complete remission, 17/32 partial remission). No serious side effects were noted. Karnofsky performance index improved in 24/26 responders.Keywords
This publication has 15 references indexed in Scilit:
- The curability of breast cancer.BMJ, 1976
- Combination Chemotherapy as an Adjuvant Treatment in Operable Breast CancerNew England Journal of Medicine, 1976
- Adriamycin—A ReviewJNCI Journal of the National Cancer Institute, 1975
- Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancerCancer, 1975
- An effective low-dose intermittent cyclophosphamide, methotrexate, and 5-fluorouracil treatment regimen for metastatic breast cancerCancer, 1975
- Combination versus single agent chemotherapy: A review of the basis for selection of drug treatment of cancerCancer, 1975
- Cyclical Combination Chemotherapy for Advanced Breast CarcinomaBMJ, 1974
- Some thoughts on experimental models and their clinical correlationsEuropean Journal of Cancer (1965), 1973
- Single and combination nonhormonal chemotherapy in breast cancerCancer, 1972
- Cancer of the breast: Size of neoplasm and prognosisCancer, 1969